152 related articles for article (PubMed ID: 34878138)
41. Molecular analysis of ciprofloxacin resistance and clonal relatedness of clinical Escherichia coli isolates from haematology patients receiving ciprofloxacin prophylaxis.
van Hees BC; Tersmette M; Willems RJ; de Jong B; Biesma D; van Hannen EJ
J Antimicrob Chemother; 2011 Aug; 66(8):1739-44. PubMed ID: 21636586
[TBL] [Abstract][Full Text] [Related]
42. Influence of RecA on in vivo virulence and Shiga toxin 2 production in Escherichia coli pathogens.
Fuchs S; Mühldorfer I; Donohue-Rolfe A; Kerényi M; Emödy L; Alexiev R; Nenkov P; Hacker J
Microb Pathog; 1999 Jul; 27(1):13-23. PubMed ID: 10371706
[TBL] [Abstract][Full Text] [Related]
43. Ciprofloxacin treatment failure in a murine model of pyelonephritis due to an AAC(6')-Ib-cr-producing Escherichia coli strain susceptible to ciprofloxacin in vitro.
Guillard T; Cambau E; Chau F; Massias L; de Champs C; Fantin B
Antimicrob Agents Chemother; 2013 Dec; 57(12):5830-5. PubMed ID: 24018262
[TBL] [Abstract][Full Text] [Related]
44. Expression of the recA gene is reduced in Escherichia coli topoisomerase I mutants.
Urios A; Herrera G; Aleixandre V; Blanco M
Mutat Res; 1990 Apr; 243(4):267-72. PubMed ID: 2157980
[TBL] [Abstract][Full Text] [Related]
45. Effect of recA inactivation on mutagenesis of Escherichia coli exposed to sublethal concentrations of antimicrobials.
Thi TD; López E; Rodríguez-Rojas A; Rodríguez-Beltrán J; Couce A; Guelfo JR; Castañeda-García A; Blázquez J
J Antimicrob Chemother; 2011 Mar; 66(3):531-8. PubMed ID: 21212055
[TBL] [Abstract][Full Text] [Related]
46. Fluoroquinolone resistance mechanisms in urinary tract pathogenic Escherichia coli isolated during rapidly increasing fluoroquinolone consumption in a low-use country.
Christiansen N; Nielsen L; Jakobsen L; Stegger M; Hansen LH; Frimodt-Møller N
Microb Drug Resist; 2011 Sep; 17(3):395-406. PubMed ID: 21668371
[TBL] [Abstract][Full Text] [Related]
47. Cellular Response to Ciprofloxacin in Low-Level Quinolone-Resistant
Machuca J; Recacha E; Briales A; Díaz-de-Alba P; Blazquez J; Pascual Á; Rodríguez-Martínez JM
Front Microbiol; 2017; 8():1370. PubMed ID: 28769919
[TBL] [Abstract][Full Text] [Related]
48. Opposing effects of aminocoumarins and fluoroquinolones on the SOS response and adaptability in Staphylococcus aureus.
Schröder W; Goerke C; Wolz C
J Antimicrob Chemother; 2013 Mar; 68(3):529-38. PubMed ID: 23169893
[TBL] [Abstract][Full Text] [Related]
49. Functional overlap between RecA and MgsA (RarA) in the rescue of stalled replication forks in Escherichia coli.
Shibata T; Hishida T; Kubota Y; Han YW; Iwasaki H; Shinagawa H
Genes Cells; 2005 Mar; 10(3):181-91. PubMed ID: 15743409
[TBL] [Abstract][Full Text] [Related]
50. Comparative genome and evolution analysis of the locus of enterocyte effacement from enteropathogenic Escherichia coli Deng and its transcriptional response to ciprofloxacin.
Chen Z; Cheng H; Pan W; Zheng J; Li D; Lin F; Yu Z; Deng Q
J Med Microbiol; 2018 Sep; 67(9):1368-1382. PubMed ID: 29989530
[TBL] [Abstract][Full Text] [Related]
51. Influence of recA mutations on gyrA dependent quinolone resistance.
Urios A; Herrera G; Aleixandre V; Blanco M
Biochimie; 1991 Apr; 73(4):519-21. PubMed ID: 1655054
[TBL] [Abstract][Full Text] [Related]
52. Temperature-dependent hypermutational phenotype in recA mutants of Thermus thermophilus HB27.
Castán P; Casares L; Barbé J; Berenguer J
J Bacteriol; 2003 Aug; 185(16):4901-7. PubMed ID: 12897010
[TBL] [Abstract][Full Text] [Related]
53. Impact of suppression of the SOS response on protein expression in clinical isolates of
Recacha E; Kuropka B; Díaz-Díaz S; García-Montaner A; González-Tortuero E; Docobo-Pérez F; Rodríguez-Rojas A; Rodríguez-Martínez JM
Front Microbiol; 2024; 15():1379534. PubMed ID: 38659986
[TBL] [Abstract][Full Text] [Related]
54. Bacterial resistance studies using in vitro dynamic models: the predictive power of the mutant prevention and minimum inhibitory antibiotic concentrations.
Firsov AA; Strukova EN; Shlykova DS; Portnoy YA; Kozyreva VK; Edelstein MV; Dovzhenko SA; Kobrin MB; Zinner SH
Antimicrob Agents Chemother; 2013 Oct; 57(10):4956-62. PubMed ID: 23896481
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
Arslan H; Azap OK; Ergönül O; Timurkaynak F;
J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
[TBL] [Abstract][Full Text] [Related]
56. Plaque color method for rapid isolation of novel recA mutants of Escherichia coli K-12: new classes of protease-constitutive recA mutants.
Tessman ES; Peterson P
J Bacteriol; 1985 Aug; 163(2):677-87. PubMed ID: 3160686
[TBL] [Abstract][Full Text] [Related]
57. (+)-Catechin potentiates the oxidative response of Acinetobacter baumannii to quinolone-based antibiotics.
Ibitoye OB; Ajiboye TO
Microb Pathog; 2019 Feb; 127():239-245. PubMed ID: 30540925
[TBL] [Abstract][Full Text] [Related]
58. Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica.
Randall LP; Cooles SW; Piddock LJ; Woodward MJ
J Antimicrob Chemother; 2004 Sep; 54(3):688-91. PubMed ID: 15243029
[TBL] [Abstract][Full Text] [Related]
59. The SOS response of Listeria monocytogenes is involved in stress resistance and mutagenesis.
van der Veen S; van Schalkwijk S; Molenaar D; de Vos WM; Abee T; Wells-Bennik MHJ
Microbiology (Reading); 2010 Feb; 156(Pt 2):374-384. PubMed ID: 19892760
[TBL] [Abstract][Full Text] [Related]
60. Mutant prevention concentrations of ciprofloxacin for urinary tract infection isolates of Escherichia coli.
Marcusson LL; Olofsson SK; Komp Lindgren P; Cars O; Hughes D
J Antimicrob Chemother; 2005 Jun; 55(6):938-43. PubMed ID: 15860549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
